Investor presentations

Sanofi and Regeneron conference call for the financial community on the results of the ODYSSEY OUTCOMES study.

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Ablynx.

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Bioverativ Inc.

Sanofi organized an analyst meeting to discuss Sanofi’s R&D strategy and development pipeline.

Sanofi and Regeneron hosted a conference call following the approval of Dupixent® in the U.S.

Sanofi and Regeneron hosted a conference call focusing on dupilumab.

Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim.

Sanofi and Regeneron hosted a conference call on sarilumab.

Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020.

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

Sanofi hosted an IR Thematic Seminar on New Medicines.

Sanofi held a conference call with Serge Weinberg for the financial community.

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.

Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions.

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting.